Peptide Coating for Titanium Osseointegration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for improving osseointegration of titanium implants, such as those using peptide coatings, face challenges in synthesizing and modifying recombinantly expressed mussel adhesion proteins with multiple bioactive molecules, leading to difficulties in achieving effective cell attachment and stability on metal surfaces.
Innovation Solution
A peptide comprising L-3,4-dihydroxyphenylalanine (DOPA), an integrin binding peptide, and a heparin binding peptide, synthesized via solid phase synthesis and click chemistry, exhibits a synergistic effect in cell adhesion to metal surfaces, particularly titanium, with enhanced stability and binding affinity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If recombinant mussel adhesion proteins are modified with multiple bioactive molecules, then cell adhesion promotion is improved, but synthesis and modification difficulty increases
Solution Approach 1:
The patent combines multiple bioactive functions (titanium binding via DOPA, integrin binding via RGD motif, and heparin binding) into a single fusion protein molecule. This merging approach allows the protein to simultaneously perform multiple functions while being synthesized as one integrated recombinant molecule, thereby promoting cell adhesion effectively while avoiding the complexity of separately synthesizing and assembling multiple modified components.
Solution Approach 2:
The fusion protein is designed with multi-functionality, containing DOPA residues for titanium surface binding, RGD motif for integrin-mediated cell adhesion, and heparin-binding domains. This universal design enables a single protein to fulfill multiple roles in the osseointegration process, simplifying the manufacturing process compared to applying separate modifications for each function.
2Reliability
If peptide coatings are applied to titanium surfaces, then osseointegration is improved, but surface functionalization complexity increases
Solution Approach 1:
The desired bioactive functions are incorporated into the fusion protein sequence during recombinant expression before the protein is applied to the titanium surface. The DOPA residues are built into the protein structure to enable titanium binding, eliminating the need for post-synthesis chemical modifications or complex surface functionalization steps. This preliminary incorporation of functionality simplifies the overall surface treatment process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide coating demonstrates excellent stability and binding affinity to titanium surfaces, promoting osseointegration by facilitating cell attachment and proliferation, with significant improvements in cell spreading and viability compared to uncoated implants.
Implementation Method 1
L-3,4-dihydroxyphenylalanine (DOPA) is known to bind to the oxidized surface of titanium without chemical treatment
Implementation Method 2
The peptide sequence FHRRIKA (Phe-His-Arg-Arg-Ile-Lys-Ala) (SEQ ID NO:1) is thought to bind to heparin-containing proteoglycans, thereby promoting cell adhesion
Implementation Method 3
In addition to integrin-binding peptides, binding to transmembrane proteoglycans has been demonstrated for peptides with basic amino acids
Data Source
Figure 1A~1C
Figure 2a~2b
Figure 3a~3c
AI summary
The invention relates to a peptide, comprising (i) a main chain comprising at least one L-3,4-dihydroxyphenylalanine (DOPA), (ii) at least one integrin-binding peptide, and (iii) at least one heparin-binding peptide. The invention further relates to a coating of metal surfaces, comprising the peptide according to the invention, and a coated metal surface that can be obtained by reacting the peptide according to the invention with a metal surface.